Reply to: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis

M. Malik Farooqi, Nathan Hambly, Christopher J. Ryerson, Martin Kolb

Source: Eur Respir J, 61 (1) 2202261; 10.1183/13993003.02261-2022

Journal Issue: January

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Malik Farooqi, Nathan Hambly, Christopher J. Ryerson, Martin Kolb. Reply to: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis. Eur Respir J, 61 (1) 2202261; 10.1183/13993003.02261-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.